{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-115965","form_type":"8-K","ticker":"CTKB","cik":"0001831915","company_name":"Cytek Biosciences, Inc.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.012494+00:00","generated_at":"2026-05-22T05:24:28.843208+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cytek Q1 revenue down 7.6% to $41.5M; net loss widens; FY2025 guidance reduced","bullets":["Revenue $41.5M (-7.6% YoY); gross margin 49% vs 51%; net loss $11.4M vs $6.2M loss prior year.","Adjusted EBITDA loss $3.3M vs $0.7M loss; cash & securities $265.6M, down $12.3M from Dec 2024.","FY2025 revenue guidance revised to $196-210M (-2% to +5% YoY); prior guidance withdrawn.","Repurchased $10.6M of common stock in Q1; launched Cytek Muse Micro instrument.","Strength in APAC and cell sorters/service business offset by US/EMEA product sales slowdown."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-115965","json":"https://secwatch.observer/filing/0001193125-25-115965.json","markdown":"https://secwatch.observer/filing/0001193125-25-115965.md","text":"https://secwatch.observer/filing/0001193125-25-115965.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831915/000119312525115965/0001193125-25-115965-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831915/000119312525115965/d926849d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T05:24:28.843208+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}